Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G Robertson

Showing results (731-740 of 816) with videos related to

Pageof 82
Sort By:
Urolithiasis|December 1, 2022
International Alliance of Urolithiasis (IAU) guidelines on the metabolic evaluation and medical management of urolithiasisGuohua Zeng, Wei Zhu, William G Robertson, et al.
Clinical Chemistry and Laboratory Medicine|June 8, 2026
Analytical and clinical performance of the updated Elecsys Anti-TPO II assay for the detection of antibodies against thyroid peroxidase to aid in the diagnosis of autoimmune thyroid diseasesKenneth D Burman, Lowell R Schmeltz, Yoko Momoyama, et al.
Bioorganic & Medicinal Chemistry Letters|October 17, 2007
Potent non-nitrile dipeptidic dipeptidyl peptidase IV inhibitorsLigaya M Simpkins, Scott Bolton, Zulan Pi, et al.
Urolithiasis|October 13, 2020
Urine and stone analysis for the investigation of the renal stone former: a consensus conferenceJames C Williams, Giovanni Gambaro, Allen Rodgers, et al.
Scientific Reports|July 13, 2022
Transatlantic spread of highly pathogenic avian influenza H5N1 by wild birds from Europe to North America in 2021V Caliendo, N S Lewis, A Pohlmann, et al.
Journal of Medicinal Chemistry|July 22, 2005
Discovery and preclinical profile of Saxagliptin (BMS-477118): a highly potent, long-acting, orally active dipeptidyl peptidase IV inhibitor for the treatment of type 2 diabetesDavid J Augeri, Jeffrey A Robl, David A Betebenner, et al.
The Review of Scientific Instruments|May 3, 2020
The design of a line velocity interferometer for any reflector for inertial confinement experiments on the Z-machineP Datte, J Baker, D Bliss, et al.
Journal of Medicinal Chemistry|April 30, 2004
Synthesis of novel potent dipeptidyl peptidase IV inhibitors with enhanced chemical stability: interplay between the N-terminal amino acid alkyl side chain and the cyclopropyl group of alpha-aminoacyl-l-cis-4,5-methanoprolinenitrile-based inhibitorsDavid R Magnin, Jeffrey A Robl, Richard B Sulsky, et al.
Nucleic Acids Research|December 31, 2005
cisRED: a database system for genome-scale computational discovery of regulatory elementsG Robertson, M Bilenky, K Lin, et al.
Journal of Medicinal Chemistry|February 12, 2008
Discovery of dapagliflozin: a potent, selective renal sodium-dependent glucose cotransporter 2 (SGLT2) inhibitor for the treatment of type 2 diabetesWei Meng, Bruce A Ellsworth, Alexandra A Nirschl, et al.
Pageof 82

Showing results (731-740 of 816) with videos related to

Sort By:
Pageof 82
Urolithiasis|December 1, 2022
International Alliance of Urolithiasis (IAU) guidelines on the metabolic evaluation and medical management of urolithiasisGuohua Zeng, Wei Zhu, William G Robertson, et al.
Clinical Chemistry and Laboratory Medicine|June 8, 2026
Analytical and clinical performance of the updated Elecsys Anti-TPO II assay for the detection of antibodies against thyroid peroxidase to aid in the diagnosis of autoimmune thyroid diseasesKenneth D Burman, Lowell R Schmeltz, Yoko Momoyama, et al.
Bioorganic & Medicinal Chemistry Letters|October 17, 2007
Potent non-nitrile dipeptidic dipeptidyl peptidase IV inhibitorsLigaya M Simpkins, Scott Bolton, Zulan Pi, et al.
Urolithiasis|October 13, 2020
Urine and stone analysis for the investigation of the renal stone former: a consensus conferenceJames C Williams, Giovanni Gambaro, Allen Rodgers, et al.
Scientific Reports|July 13, 2022
Transatlantic spread of highly pathogenic avian influenza H5N1 by wild birds from Europe to North America in 2021V Caliendo, N S Lewis, A Pohlmann, et al.
Journal of Medicinal Chemistry|July 22, 2005
Discovery and preclinical profile of Saxagliptin (BMS-477118): a highly potent, long-acting, orally active dipeptidyl peptidase IV inhibitor for the treatment of type 2 diabetesDavid J Augeri, Jeffrey A Robl, David A Betebenner, et al.
The Review of Scientific Instruments|May 3, 2020
The design of a line velocity interferometer for any reflector for inertial confinement experiments on the Z-machineP Datte, J Baker, D Bliss, et al.
Journal of Medicinal Chemistry|April 30, 2004
Synthesis of novel potent dipeptidyl peptidase IV inhibitors with enhanced chemical stability: interplay between the N-terminal amino acid alkyl side chain and the cyclopropyl group of alpha-aminoacyl-l-cis-4,5-methanoprolinenitrile-based inhibitorsDavid R Magnin, Jeffrey A Robl, Richard B Sulsky, et al.
Nucleic Acids Research|December 31, 2005
cisRED: a database system for genome-scale computational discovery of regulatory elementsG Robertson, M Bilenky, K Lin, et al.
Journal of Medicinal Chemistry|February 12, 2008
Discovery of dapagliflozin: a potent, selective renal sodium-dependent glucose cotransporter 2 (SGLT2) inhibitor for the treatment of type 2 diabetesWei Meng, Bruce A Ellsworth, Alexandra A Nirschl, et al.
Pageof 82